SMTL ID : 9juy.1

X-ray crystal structure of Y16513 in CBP

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.42 Å

Oligo State

monomer

Ligands

1 x 01: (5~{S})-1-(3-chloranyl-4-methoxy-phenyl)-5-[4-(3-methyl-1,2-benzoxazol-5-yl)-1-[(2~{S})-2-morpholin-4-ylpropyl]imidazol-2-yl]pyrrolidin-2-one

01.1: 11 residues within 4Å: Chain A: L.45, P.46, V.51, L.56, I.58, Y.61, Y.103, N.104, R.109, V.110, F.113 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:P.46, A:L.56, A:L.56, A:I.58, A:V.110, A:V.110 Hydrogen bonds: A:N.104, A:R.109 Water bridges: A:Y.61, A:Y.61 pi-Cation interactions: A:R.109

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 1 residues within 4Å: Chain A: R.105 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hu, J.K. et al., Discovery of 5-imidazole-3-methylbenz[d]isoxazole derivatives as potent and selective CBP/p300 bromodomain inhibitors for the treatment of acute myeloid leukemia. Acta Pharmacol.Sin. (2025)

Release Date

2025-03-12

Peptides

CREB-binding protein: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CREB-binding protein

Related Entries With Identical Sequence